B F Burkey

525 total citations
8 papers, 462 citations indexed

About

B F Burkey is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, B F Burkey has authored 8 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in B F Burkey's work include Neuropeptides and Animal Physiology (3 papers), Peptidase Inhibition and Analysis (3 papers) and Diabetes Treatment and Management (3 papers). B F Burkey is often cited by papers focused on Neuropeptides and Animal Physiology (3 papers), Peptidase Inhibition and Analysis (3 papers) and Diabetes Treatment and Management (3 papers). B F Burkey collaborates with scholars based in United States, Switzerland and Italy. B F Burkey's co-authors include Marlene J. Juedes, Jörg Trappe, Ulrich Hassiepen, Peter Hoffmann, James R. Paterniti, Manisha Mone, Margarita de la Llera Moya, J B Swaney, Mary E. Russell and Leonardo Bolognese and has published in prestigious journals such as Journal of Lipid Research, Journal of Pharmacology and Experimental Therapeutics and Diabetes Obesity and Metabolism.

In The Last Decade

B F Burkey

8 papers receiving 446 citations

Peers

B F Burkey

ONCOL

EDM

MB

SURGE

CMN

Colleen Pineda United States

Audrey Helleboid‐Chapman France

Tadashi Nagakura Japan

Stefan Tschopp Switzerland

Eun Kyoung Yang South Korea

Qi Ma China

Nathalie Delesque-Touchard France

M. Dodson Michael United States

Kyle T. Keyes United States

Daniel Franco United States

Colleen Pineda United States

B F Burkey

195 ×0.8

ONCOL

336 ×1.4

EDM

114 ×0.8

MB

97 ×0.7

SURGE

129 ×1.3

CMN

Citations per year, relative to B F Burkey B F Burkey (= 1×) peers Colleen Pineda

Countries citing papers authored by B F Burkey

Since Specialization

Citations

This map shows the geographic impact of B F Burkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B F Burkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B F Burkey more than expected).

Fields of papers citing papers by B F Burkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B F Burkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B F Burkey. The network helps show where B F Burkey may publish in the future.

Co-authorship network of co-authors of B F Burkey

This figure shows the co-authorship network connecting the top 25 collaborators of B F Burkey. A scholar is included among the top collaborators of B F Burkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B F Burkey. B F Burkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bianchi, Roberto, Ilaria Cervellini, Carla Porretta‐Serapiglia, et al.. (2011). Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy. Journal of Pharmacology and Experimental Therapeutics. 340(1). 64–72. 47 indexed citations

2.

Burkey, B F, et al.. (2008). Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited. Diabetes Obesity and Metabolism. 10(11). 1057–1061. 86 indexed citations

3.

Burkey, B F, M Kellis, Leonardo Bolognese, et al.. (2005). Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats. Journal of Pharmacology and Experimental Therapeutics. 315(2). 688–695. 95 indexed citations

4.

Fournier, Natalie, Margarita de la Llera Moya, B F Burkey, et al.. (1996). Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.. Journal of Lipid Research. 37(8). 1704–1711. 95 indexed citations

5.

Marsh, Julian B., Margaret R. Diffenderfer, Edward A. Fisher, et al.. (1996). Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene. Journal of Lipid Research. 37(5). 1113–1124. 1 indexed citations

6.

Burkey, B F, Dennis S. France, Xiaowen Ma, et al.. (1995). Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis. Journal of Lipid Research. 36(7). 1463–1473. 8 indexed citations

7.

Burkey, B F, et al.. (1992). Hepatic apolipoprotein J is secreted as a lipoprotein.. Journal of Lipid Research. 33(10). 1517–1526. 45 indexed citations

8.

Burkey, B F, et al.. (1991). Intracellular processing of apolipoprotein J precursor to the mature heterodimer.. Journal of Lipid Research. 32(6). 1039–1048. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact